Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX3IDD
|
||||
| Drug Name |
[(S)-1-((R)-1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid adamantan-2-yl ester
|
||||
| Synonyms |
CHEMBL197509
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H36N2O4
|
||||
| Canonical SMILES |
CCCC[C@H](NC(=O)OC1C2CC3CC(CC1C3)C2)C(=O)C(=O)N[C@H](C)c4ccccc4
|
||||
| InChI |
InChI=1S/C26H36N2O4/c1-3-4-10-22(23(29)25(30)27-16(2)19-8-6-5-7-9-19)28-26(31)32-24-20-12-17-11-18(14-20)15-21(24)13-17/h5-9,16-18,20-22,24H,3-4,10-15H2,1-2H3,(H,27,30)(H,28,31)/t16-,17?,18?,20?,21?,22+,24?/m1/s1
|
||||
| InChIKey |
QFJGHQXICGBKTL-GFAXYUDLSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.